Cancer News and Research

Latest Cancer News and Research

Concord Medical Services Holdings' directors approve share repurchase program

Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its board of directors approved a share repurchase program, effective immediately.

1 Oct 2011

Prostate cancer patients treated with CyberKnife Robotic Radiosurgery System enrolled in RPCR

The CyberKnife Coalition announced today that more than 500 men treated with the CyberKnife Robotic Radiosurgery System have now been enrolled in the first national patient registry designed specifically to track prostate cancer patients treated with stereotactic body radiation therapy.

1 Oct 2011

Survey calls for greater clinical consensus on diagnosis, treatment of breakthrough cancer pain

Today, the results from a European Survey of Oncology Nurse Breakthrough Cancer Pain Practices were presented for the first time at The European Multidisciplinary Cancer Congress in Stockholm.

1 Oct 2011

UAB Comprehensive Cancer Center receives NCI grant to renew support for cancer research program

The University of Alabama at Birmingham Comprehensive Cancer Center has received a five-year, $27.5 million Cancer Center Support Grant from the National Cancer Institute to renew support for its cancer research program through 2016.

1 Oct 2011

Blueberry powder may control triple negative breast cancer

In several studies recently conducted at the Beckman Research Institute at the City of Hope, Duarte, CA researchers found that feeding blueberry powder to mice significantly reduced the growth and spread of triple negative breast cancer cells, a very aggressive form of cancer.

1 Oct 2011

ShurTech Brands to donate $100,000 to BCRF

According to the American Cancer Society, after lung cancer, breast cancer is the second leading cause of cancer death in women. So, for the third consecutive year, ShurTech Brands, LLC, marketers of the Duck brand of duct tapes, packaging supplies and home products, is joining the fight to find a cure by contributing up to $100,000 to The Breast Cancer Research Foundation.

1 Oct 2011

Express Scripts launches suite of services through HealthBridge Pharma & Biotech

Express Scripts has launched a suite of services for pharmaceutical and biotech companies through HealthBridge Pharma & Biotech, providing a single-solution approach to patient care.

1 Oct 2011

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Vertex Pharmaceuticals Incorporated today announced that abstracts from its hepatitis C program, including two late-breaking posters from studies of INCIVEK (telaprevir) tablets and VX-222, were accepted for presentation at The Liver Meeting, the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, November 4-8, 2011.

1 Oct 2011

Fred Hutchinson Cancer Research Center scientist wins NIH Director's Early Indpendence Award

Carissa Perez Olsen, Ph.D., a Weintraub Scholar in the Basic Sciences Division of Fred Hutchinson Cancer Research Center, is the recipient of the National Institutes of Health Director's Early Independence Award, announced today. She is among the first group of 10 junior U.S. investigators to receive the honor.

1 Oct 2011

The West Clinic forms new comprehensive breast center

The West Clinic, the Mid-South's premier cancer practice, is pleased to announce the formation of The West Clinic Comprehensive Breast Center, a multidisciplinary breast center, which will be the first center of its kind in the region.

1 Oct 2011

Poll: 21.4% of Americans believe vaccines can cause autism

More than one-quarter of Americans are concerned about the value and safety of vaccines and 21.4 percent believe vaccines can cause autism, according to the Thomson Reuters-NPR Health Poll.

1 Oct 2011

Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against cancer

Circadian Technologies Limited is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug application to the U.S. Food and Drug Administration to initiate clinical studies of VGX-100.

1 Oct 2011

ADVENTRX holds Type A meeting with FDA to discuss Exelbine NDA

ADVENTRX Pharmaceuticals, Inc. announced today that it held a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the complete response letter (CRL) it received in August from the FDA regarding the Company's New Drug Application (NDA) for Exelbine (vinorelbine injectable emulsion) for the treatment of non-small cell lung cancer.

1 Oct 2011

Patients enrolled in consumer-directed health plans have control over health care spending

The historic RAND Health Insurance Experiment found that patients had little or no control over their health care spending once they began to receive a physician's care, but a new study shows that this has changed for those enrolled in consumer-directed health plans.

30 Sep 2011

Young woman fights tobacco within the Hispanic Community

Twenty-five year old Anna Luzania knows first-hand the effects of tobacco in the Hispanic Community. As a student at California State University (CSU) at Fresno, she did what many young people enjoying their first years of college do not -- she took action to save the lives of her fellow students and community.

30 Sep 2011

Roche inaugurates new clinical supply manufacturing facility in Nutley, N.J.

Roche announced today the opening of a new state-of-the-art clinical supply manufacturing facility on its campus in Nutley, N.J. The Roche Center of Excellence produces dosage forms of highly potent compounds for preclinical safety studies, and Phase 1 and 2 clinical studies.

30 Sep 2011

New targeting approach to develop an active site-directed, drug-like PTP1B inhibitor

The work of a team of scientists at Cold Spring Harbor Laboratory (CSHL) led by Professor Nicholas Tonks FRS, suggests a way to overcome one of the major technical obstacles preventing a leading therapeutic target for diabetes and obesity from being addressed successfully by novel drugs.

30 Sep 2011

Free radical peroyxnitrite linked to failure of cytotoxic T-cells to eliminate tumors

Researchers at the Moffitt Cancer Center in Tampa, Fla., and colleagues have found that tumor cell resistance to a specific cancer immunotherapy designed to kill cancer cells can be blamed on a mechanism that involves the production of a free radical peroxynitrite (PNT) that causes resistance to therapeutic cancer-killing cells.

30 Sep 2011

Estradiol plays an important role in several metabolic diseases

Hormone researchers at the University of Houston (UH) have their sights set on providing long-term treatment options for diabetes, obesity and cardiovascular diseases by better understanding estradiol, the most potent naturally occurring estrogen.

30 Sep 2011

ALK gene discovered by St. Jude scientists associated with FDA approved adult cancer drug

A drug recently approved by the U.S. Food and Drug Administration for treatment of an adult cancer targets a malfunctioning gene discovered more than a decade earlier at St. Jude Children's Research Hospital. The story highlights how scientific findings from St. Jude can be translated into therapies and tests that in addition to helping children, also help adults.

30 Sep 2011

Cancer News and Research

Latest Cancer News and Research

Concord Medical Services Holdings' directors approve share repurchase program

Prostate cancer patients treated with CyberKnife Robotic Radiosurgery System enrolled in RPCR

Survey calls for greater clinical consensus on diagnosis, treatment of breakthrough cancer pain

UAB Comprehensive Cancer Center receives NCI grant to renew support for cancer research program

Blueberry powder may control triple negative breast cancer

ShurTech Brands to donate $100,000 to BCRF

Express Scripts launches suite of services through HealthBridge Pharma & Biotech

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Fred Hutchinson Cancer Research Center scientist wins NIH Director's Early Indpendence Award

The West Clinic forms new comprehensive breast center

Poll: 21.4% of Americans believe vaccines can cause autism

Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against cancer

ADVENTRX holds Type A meeting with FDA to discuss Exelbine NDA

Patients enrolled in consumer-directed health plans have control over health care spending

Young woman fights tobacco within the Hispanic Community

Roche inaugurates new clinical supply manufacturing facility in Nutley, N.J.

New targeting approach to develop an active site-directed, drug-like PTP1B inhibitor

Free radical peroyxnitrite linked to failure of cytotoxic T-cells to eliminate tumors

Estradiol plays an important role in several metabolic diseases

ALK gene discovered by St. Jude scientists associated with FDA approved adult cancer drug

Cancer Research - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in